The study includes efficacy as a secondary outcome measure… so, hopefully some of those measures are included, in particular Objective Response Rate however it may be too early for some of the other outcome measures.
The CF33, Vaxinia and Oncarlytics Deal, page-828
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(1.92%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $54.37K | 1.031M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 2332350 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1534925 | 19 |
View Market Depth
| Last trade - 12.22pm 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |